SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tse, W. S.
Right arrow Articles by Bond, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tse, W. S.
Right arrow Articles by Bond, A. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Serotonergic involvement in the psychosocial dimension of personality

Wai S. Tse

Section of Clinical Psychopharmacology; Institute of Psychiatry; De Crespigny Park; London SE5 8AF; UK: spklwst{at}iop.kcl.ac.uk

Alyson J. Bond

Section of Clinical Psychopharmacology, Division of Psychological Medicine, Institute of Psychiatry, King's College London, UK

Neurotransmitter systems have been associated with aspects of personality and changes in various dimensions have been shown after antidepressant treatment. A reduction in harm avoidance and an increase in self-directedness and cooperativeness, as measured by the Cloninger's Temperament and Character Inventory (TCI), have been reported in psychiatric patients receiving treatment with serotonergic antidepressants. However, some of these changes have been associated with clinical improvement. The present study therefore used a randomized, double-blind, placebo-controlled design to examine the role of the serotonergic system on these personality factors in the normal population. Twenty healthy male volunteers were randomly allocated to either placebo (n = 9) or citalopram treatment (n = 11) for 2 weeks. Baseline depression and anxiety scores were low and did not differ between groups. The TCI was administered pre-and post-treatment. There were no baseline differences on any TCI factor between groups. Citalopram induced a significant increase in self-directedness (p< 0.05) but not cooperativeness or harm avoidance ratings after treatment. Thus, citalopram has effects on personality aspects which appear to be separate from its antidepressant properties.

Key Words: antidepressant • personality • serotonin

Journal of Psychopharmacology, Vol. 15, No. 3, 195-198 (2001)
DOI: 10.1177/026988110101500313


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
T. Z. Tang, R. J. DeRubeis, S. D. Hollon, J. Amsterdam, R. Shelton, and B. Schalet
Personality Change During Depression Treatment: A Placebo-Controlled Trial
Arch Gen Psychiatry, December 1, 2009; 66(12): 1322 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
N. MacInnes, S. L. Handley, and G. F.A. Harding
The BDI of the beholder: an eye to experimental design
J Psychopharmacol, May 1, 2002; 16(3): 273 - 273.
[PDF]


Home page
J PsychopharmacolHome page
J. C. Cole and H. R. Sumnall
The BDI of the beholder
J Psychopharmacol, January 1, 2002; 16(1): 103 - 103.
[PDF]



Advertisement